| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780839 | Gynecologic Oncology | 2017 | 9 Pages |
Abstract
Rucaparib has antitumor activity in advanced BRCA1/2-mutated HGOC and a manageable safety profile.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Amit M. Oza, Anna V. Tinker, Ana Oaknin, Ronnie Shapira-Frommer, Iain A. McNeish, Elizabeth M. Swisher, Isabelle Ray-Coquard, Katherine Bell-McGuinn, Robert L. Coleman, David M. O'Malley, Alexandra Leary, Lee-may Chen, Diane Provencher, Ling Ma,